Company intelligence / Profile preview

Unither Pharmaceuticals

Amiens, Hauts-de-France, Franceunither-pharma.us ↗

Ownership: Private
Employees: ~2000
Development stage: Commercial

Overview

Unither Pharmaceuticals operates as a global leader in contract development and manufacturing of pharmaceutical products, especially in sterile and non-sterile liquid forms. The company’s pipeline includes both proprietary and generic formulations, with several programs at various clinical stages up to Phase III. Their BFS technology enables large-scale production of sterile single-dose units for ophthalmic, respiratory, and oral applications. They have achieved commercial status with multiple approved products worldwide.

Therapeutic areas: OphthalmologyNeurologyInfectious Diseases
Modalities: Small moleculesProphylactic vaccinesCombination products
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Unither Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unither Pharmaceuticals.

Explore the full profile